We provide you with 20 years of free, institutional-grade data for XNCR stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of XNCR. Explore the full financial landscape of XNCR stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-06 | 1326732 | XNCR | 10-Q | Url |
| 2025-05-07 | 1326732 | XNCR | 10-Q | Url |
| 2025-02-27 | 1326732 | XNCR | 10-K | Url |
| 2024-11-06 | 1326732 | XNCR | 10-Q | Url |
| 2024-08-05 | 1326732 | XNCR | 10-Q | Url |
| 2024-05-09 | 1326732 | XNCR | 10-Q | Url |
| 2024-02-29 | 1326732 | XNCR | 10-K | Url |
| 2023-11-08 | 1326732 | XNCR | 10-Q | Url |
| 2023-08-03 | 1326732 | XNCR | 10-Q | Url |
| 2023-05-08 | 1326732 | XNCR | 10-Q | Url |
| 2023-02-27 | 1326732 | XNCR | 10-K | Url |
| 2022-11-07 | 1326732 | XNCR | 10-Q | Url |
| 2022-08-03 | 1326732 | XNCR | 10-Q | Url |
| 2022-05-05 | 1326732 | XNCR | 10-Q | Url |
| 2022-02-24 | 1326732 | XNCR | 10-K | Url |
| 2021-11-08 | 1326732 | XNCR | 10-Q | Url |
| 2021-08-04 | 1326732 | XNCR | 10-Q | Url |
| 2021-05-05 | 1326732 | XNCR | 10-Q | Url |
| 2021-02-24 | 1326732 | XNCR | 10-K | Url |
| 2020-11-06 | 1326732 | XNCR | 10-Q | Url |
| 2020-08-05 | 1326732 | XNCR | 10-Q | Url |
| 2020-05-08 | 1326732 | XNCR | 10-Q | Url |
| 2020-02-25 | 1326732 | XNCR | 10-K | Url |
| 2019-11-05 | 1326732 | XNCR | 10-Q | Url |
| 2019-08-07 | 1326732 | XNCR | 10-Q | Url |
| 2019-05-09 | 1326732 | XNCR | 10-Q | Url |
| 2019-02-26 | 1326732 | XNCR | 10-K | Url |
| 2018-11-05 | 1326732 | XNCR | 10-Q | Url |
| 2018-08-07 | 1326732 | XNCR | 10-Q | Url |
| 2018-05-07 | 1326732 | XNCR | 10-Q | Url |
| 2018-02-28 | 1326732 | XNCR | 10-K | Url |
| 2017-11-08 | 1326732 | XNCR | 10-Q | Url |
| 2017-08-07 | 1326732 | XNCR | 10-Q | Url |
| 2017-05-10 | 1326732 | XNCR | 10-Q | Url |
| 2017-03-01 | 1326732 | XNCR | 10-K | Url |
| 2016-11-02 | 1326732 | XNCR | 10-Q | Url |
| 2016-08-03 | 1326732 | XNCR | 10-Q | Url |
| 2016-05-02 | 1326732 | XNCR | 10-Q | Url |
| 2016-03-08 | 1326732 | XNCR | 10-K | Url |
| 2015-11-04 | 1326732 | XNCR | 10-Q | Url |
| 2015-08-05 | 1326732 | XNCR | 10-Q | Url |
| 2015-05-05 | 1326732 | XNCR | 10-Q | Url |
| 2015-02-20 | 1326732 | XNCR | 10-K | Url |
| 2014-11-10 | 1326732 | XNCR | 10-Q | Url |
| 2014-08-01 | 1326732 | XNCR | 10-Q | Url |
| 2014-05-15 | 1326732 | XNCR | 10-Q | Url |
| 2014-03-31 | 1326732 | XNCR | 10-K | Url |
| 2013-10-11 | 1326732 | XNCR | S-1 | Url |
Xencor, Inc(NASDAQ:XNCR) 
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases in the United states and internationally. The company's product candidates include Obex...
Website: http://www.xencor.com
Founded: 1997
Full Time Employees: 166
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about XNCR stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.